| Medicine in the early twenty-first century: paradigm and anticipation-EPMA position paper 2016 O Golubnitschaja, B Baban, G Boniolo, W Wang, R Bubnov, M Kapalla, ... EPMA Journal 7 (1), 23, 2016 | 349 | 2016 |
| General report & recommendations in predictive, preventive and personalised medicine 2012: white paper of the European Association for Predictive, Preventive and Personalised … O Golubnitschaja, V Costigliola, ... EPMA Journal 3, 1-53, 2012 | 278 | 2012 |
| Flammer syndrome K Konieczka, R Ritch, CE Traverso, DM Kim, MS Kook, A Gallino, ... Epma Journal 5, 1-7, 2014 | 233 | 2014 |
| Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine E Avishai, K Yeghiazaryan, O Golubnitschaja EPMA Journal 8, 23-33, 2017 | 228 | 2017 |
| Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention A Kapinova, P Kubatka, O Golubnitschaja, M Kello, P Zubor, P Solar, ... Environmental health and preventive medicine 23, 1-18, 2018 | 180 | 2018 |
| Chronic inflammation: key player and biomarker-set to predict and prevent cancer development and progression based on individualized patient profiles S Qian, O Golubnitschaja, X Zhan Epma Journal 10 (4), 365-381, 2019 | 162 | 2019 |
| Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures O Golubnitschaja, M Debald, K Yeghiazaryan, W Kuhn, M Pešta, ... Tumor Biology 37, 12941-12957, 2016 | 154 | 2016 |
| Predictive, preventive and personalised medicine as the hardcore of ‘Horizon 2020’: EPMA position paper O Golubnitschaja, J Kinkorova, V Costigliola EPMA Journal 5, 1-29, 2014 | 154 | 2014 |
| Artificial intelligence supported patient self-care in chronic heart failure: a paradigm shift from reactive to predictive, preventive and personalised care M Barrett, J Boyne, J Brandts, HP Brunner-La Rocca, L De Maesschalck, ... Epma Journal 10, 445-464, 2019 | 143 | 2019 |
| Birth asphyxia as the major complication in newborns: moving towards improved individual outcomes by prediction, targeted prevention and tailored medical care O Golubnitschaja, K Yeghiazaryan, M Cebioglu, M Morelli, ... EPMA Journal 2, 197-210, 2011 | 143 | 2011 |
| Comet assay analysis of single–stranded DNA breaks in circulating leukocytes of glaucoma patients M Mozaffarieh, A Schoetzau, M Sauter, M Grieshaber, S Orgül, ... Molecular vision 14, 1584, 2008 | 109 | 2008 |
| What are the biomarkers for glaucoma? O Golubnitschaja, J Flammer Survey of ophthalmology 52 (6), S155-S161, 2007 | 107 | 2007 |
| Caution,“normal” BMI: health risks associated with potentially masked individual underweight—EPMA Position Paper 2021 O Golubnitschaja, A Liskova, L Koklesova, M Samec, K Biringer, ... EPMA Journal 12 (3), 243-264, 2021 | 103 | 2021 |
| “Pre-metastatic niches” in breast cancer: are they created by or prior to the tumour onset?“Flammer Syndrome” relevance to address the question R Bubnov, J Polivka Jr, P Zubor, K Konieczka, O Golubnitschaja EPMA Journal 8 (2), 141-157, 2017 | 102 | 2017 |
| Flavonoids against the Warburg phenotype—Concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism M Samec, A Liskova, L Koklesova, SM Samuel, K Zhai, C Buhrmann, ... Epma Journal 11, 377-398, 2020 | 100 | 2020 |
| Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person L Koklesova, A Mazurakova, M Samec, K Biringer, SM Samuel, ... EPMA Journal 12, 477-505, 2021 | 95 | 2021 |
| Increased expression of matrix metalloproteinases in mononuclear blood cells of normal-tension glaucoma patients O Golubnitschaja, K Yeghiazaryan, R Liu, H Mönkemann, D Leppert, ... Journal of glaucoma 13 (1), 66-72, 2004 | 95 | 2004 |
| All around suboptimal health—a joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine W Wang, Y Yan, Z Guo, H Hou, M Garcia, X Tan, EO Anto, G Mahara, ... EPMA Journal 12, 403-433, 2021 | 92 | 2021 |
| Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation M Kropp, O Golubnitschaja, A Mazurakova, L Koklesova, N Sargheini, ... Epma Journal 14 (1), 21-42, 2023 | 91 | 2023 |
| Flavonoids as an effective sensitizer for anti-cancer therapy: Insights into multi-faceted mechanisms and applicability towards individualized patient profiles A Liskova, M Samec, L Koklesova, A Brockmueller, K Zhai, B Abdellatif, ... Epma Journal 12 (2), 155-176, 2021 | 89 | 2021 |
Peter KubatkaProfessor, Comenius University in Bratislava在 uniba.sk 的电子邮件经过验证
